Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/21508| Title: | Screening and Prophylaxis to Prevent Hepatitis B Reactivation: Transplant Recipients. | Austin Authors: | Sasadeusz, Joe;Grigg, Andrew P ;Hughes, Peter D;Lee Lim, Seng;Lucas, Michaela;McColl, Geoff;McLachlan, Sue Anne;Peters, Marion G;Shackel, Nicholas;Slavin, Monica;Sundararajan, Vijaya;Thompson, Alexander;Doyle, Joseph;Rickard, James;De Cruz, Peter;Gish, Robert G;Visvanathan, Kumar | Affiliation: | Olivia Newton-John Cancer Research Institute, Heidelberg, Victoria, Australia University of California, San Francisco, S357 Parnassus Avenue, San Francisco, CA 94143, USA University of Queensland Oral Health Centre, 288 Herston Road, Queensland 4006, Australia Ingham Institute, 1 Campbell Street, Liverpool, Sydney, New South Wales 2170, Australia Victorian Comprehensive Cancer Centre, 305 Grattan Street, Melbourne, Victoria 3000, Australia Department of Public Health, La Trobe University, Plenty Road, Bundoora, Victoria 3086, Australia Burnet Institute, 85 Commercial Road, Melbourne, Victoria 3004, Australia The Alfred and Monash University, 85 Commercial Road, Melbourne, Victoria 3004, Australia University of Melbourne, Grattan Street, Parkville, Victoria 3010, Australia Peter Doherty Institute for Infection and Immunity, Elizabeth Street, Melbourne, Victoria 3000, Australia Division of Gastroenterology and Hepatology, Department of Medicine, Stanford University, Stanford University Medical Center, 300 Pasteur Drive, Stanford, CA 94305, USA University of Western Australia, 35 Stirling Highway, Crawley, Western Australia 6009, Australia St Vincent's Hospital, 41 Victoria Street, Fitzroy, Victoria 3065, Australia Royal Melbourne Hospital, 300 Grattan Street, Parkville, Victoria 3050, Australia National University of Singapore, 21 Lower Kent Ridge Road, Singapore 119077, Singapore |
Issue Date: | Aug-2019 | Date: | 2019-06-06 | Publication information: | Clinics in liver disease 2019; 23(3): 493-509 | Abstract: | Organ transplantation is a lifesaving procedure for many patients. To prevent rejection or graft-versus-host disease, recipients require long-term immunosuppression. In patients who have ever been exposed to hepatitis B, it is possible for reactivation to occur; this includes patients who are anti-hepatitis B core antibody-positive only or both anti-hepatitis B core antibody-positive and hepatitis B surface antibody-positive. The susceptibility to this varies with the nature of the transplant. Hepatitis B can be transmitted from donor to recipient. It is important to assess the hepatitis B status and formulate a strategy to prevent transmission and prevent reactivation. | URI: | https://ahro.austin.org.au/austinjspui/handle/1/21508 | DOI: | 10.1016/j.cld.2019.04.010 | Journal: | Clinics in liver disease | PubMed URL: | 31266623 | Type: | Journal Article | Subjects: | Hepatitis B Prophylaxis Reactivation Transmission Transplantation |
| Appears in Collections: | Journal articles |
Show full item record
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.